Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pregnancy in scleroderma.

Virginia D Steen1

  • 1Department of Medicine, Georgetown University Medical Center, Washington, DC 20007, USA. steenv@georgetown.edu

Rheumatic Diseases Clinics of North America
|May 15, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autoantibody associations in patients with early diffuse cutaneous systemic sclerosis: the prospective registry of early systemic sclerosis.

Seminars in arthritis and rheumatism·2026
Same author

Combining Pirfenidone With Mycophenolate Mofetil for Systemic Sclerosis-Related Interstitial Lung Disease (Scleroderma Lung Study III): An Investigator-Initiated, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.

ACR open rheumatology·2025
Same author

Association of Type III and Type VI Collagen Neoepitopes With Disease Severity in Systemic Sclerosis.

The Journal of rheumatology·2025
Same author

'Am I doing this right?' Physician perceptions of the global assessment in clinical trials of systemic sclerosis.

Rheumatology (Oxford, England)·2025
Same author

Hand Swelling and Other Non-Raynaud Phenomenon Symptoms as the Initial Presentation of Systemic Sclerosis: Prevalence and Clinical Associations in Two US Cohorts.

Arthritis & rheumatology (Hoboken, N.J.)·2025
Same author

Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United States.

Annals of the American Thoracic Society·2025
Same journal

Rheumatology at the Threshold of Artificial Intelligence.

Rheumatic diseases clinics of North America·2026
Same journal

Foreword.

Rheumatic diseases clinics of North America·2026
Same journal

Artificial Intelligence Regulation in the United States: Current Landscape and Implications for Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

The Role of Artificial Intelligence in Medical Education and Training: Implications for Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Sources of Bias in Clinical Artificial Intelligence and Applications in Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Toward Bridging the Gap from Artificial Intelligence in Clinical Research to Clinical Practice in Rheumatology: The Mayo Experience.

Rheumatic diseases clinics of North America·2026
See all related articles

Pregnancy in systemic sclerosis can be successful with careful monitoring. Women with diffuse scleroderma should delay pregnancy until their condition stabilizes to minimize risks.

Area of Science:

  • Rheumatology
  • Obstetrics
  • Maternal-Fetal Medicine

Background:

  • Systemic sclerosis is a multisystem autoimmune disease.
  • Pregnancy in patients with systemic sclerosis presents unique challenges.
  • Potential complications can affect both mother and fetus.

Purpose of the Study:

  • To review the management of pregnancy in women with systemic sclerosis.
  • To highlight key considerations for optimizing maternal and fetal outcomes.
  • To emphasize the importance of multidisciplinary care.

Main Methods:

  • Review of existing literature on pregnancy and systemic sclerosis.
  • Discussion of risk stratification based on disease subtype and activity.
  • Emphasis on comprehensive antenatal and intrapartum surveillance.

Related Experiment Videos

Main Results:

  • Pregnancy can be uneventful with good outcomes when managed appropriately.
  • Diffuse scleroderma poses higher risks for cardiopulmonary and renal complications.
  • Early disease stabilization is recommended before conception for women with diffuse scleroderma.

Conclusions:

  • Careful antenatal evaluation and high-risk obstetric monitoring are crucial.
  • Vigilant monitoring for renal crisis is essential in pregnant patients with systemic sclerosis.
  • Optimizing outcomes requires a proactive and individualized approach to care.